What causes very low homocysteine?

Very low homocysteine levels (below 5 μmol/L) can result from excessive B-vitamin supplementation, malnutrition, liver disease, or genetic factors. While less concerning than high levels, extremely low homocysteine may indicate underlying health issues that warrant investigation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Homocysteine and Its Role in Your Body

Homocysteine is an amino acid produced naturally in your body as a byproduct of methionine metabolism. This sulfur-containing compound plays a crucial role in various metabolic processes, including the production of other important amino acids like cysteine and the recycling of methionine through methylation pathways.

While much attention focuses on elevated homocysteine levels and their association with cardiovascular disease, very low homocysteine levels can also signal underlying health issues. Normal homocysteine levels typically range from 5 to 15 μmol/L, with optimal levels generally considered to be between 6 and 10 μmol/L. When levels drop below 5 μmol/L, it may indicate disruptions in normal metabolic processes.

Primary Causes of Very Low Homocysteine

Excessive B-Vitamin Supplementation

The most common cause of very low homocysteine is excessive supplementation with B vitamins, particularly folate (B9), vitamin B12, and vitamin B6. These vitamins are essential cofactors in homocysteine metabolism, helping convert it to either methionine or cysteine. When taken in very high doses, they can drive homocysteine levels below the normal range.

This over-supplementation effect is particularly pronounced with synthetic folic acid, which can be more potent than naturally occurring folate. Some individuals taking high-dose B-complex supplements or receiving B12 injections may experience this dramatic reduction in homocysteine levels. While this might seem beneficial given the risks of elevated homocysteine, extremely low levels may interfere with normal sulfur metabolism and other physiological processes.

Malnutrition and Protein Deficiency

Paradoxically, severe malnutrition can also lead to very low homocysteine levels. Since homocysteine is derived from methionine, an essential amino acid obtained from dietary protein, inadequate protein intake can result in insufficient substrate for homocysteine production. This is particularly common in:

  • Individuals with eating disorders, especially anorexia nervosa
  • Those following extremely restrictive diets without proper nutritional planning
  • Elderly individuals with poor appetite or difficulty eating
  • People experiencing severe gastrointestinal disorders affecting nutrient absorption

Liver Disease and Dysfunction

The liver plays a central role in homocysteine metabolism, as most homocysteine processing occurs in hepatic cells. Various liver conditions can impair the organ's ability to properly metabolize methionine and produce homocysteine, leading to abnormally low levels. These conditions include chronic hepatitis, cirrhosis, fatty liver disease, and acute liver failure.

In liver disease, the disruption of normal metabolic pathways can affect multiple aspects of homocysteine metabolism, including the transsulfuration pathway that converts homocysteine to cysteine and the remethylation pathway that converts it back to methionine. Regular monitoring of liver function alongside homocysteine levels can help identify these connections.

Genetic and Metabolic Factors

CBS Gene Upregulation

Genetic variations affecting the cystathionine beta-synthase (CBS) enzyme can lead to increased activity of the transsulfuration pathway, which converts homocysteine to cystathionine and eventually to cysteine. Individuals with CBS gene upregulation may naturally have lower homocysteine levels due to enhanced conversion. This genetic variation is relatively common and may be beneficial in some contexts but can also lead to other metabolic imbalances.

MTHFR Gene Variations

While MTHFR gene mutations are typically associated with elevated homocysteine, certain combinations of genetic variations along with high-dose supplementation can paradoxically lead to very low levels. The methylenetetrahydrofolate reductase (MTHFR) enzyme is crucial for converting folate to its active form, which is then used in homocysteine remethylation. Understanding your genetic profile can help optimize supplementation strategies.

Other Contributing Factors

Pregnancy and Hormonal Changes

During pregnancy, homocysteine levels naturally decrease due to hemodilution, increased renal clearance, and hormonal changes. Estrogen, which increases during pregnancy, enhances homocysteine metabolism. While this reduction is generally protective, extremely low levels might warrant investigation to ensure adequate nutrition and proper fetal development.

Certain Medications

Some medications can influence homocysteine metabolism and lead to lower levels:

  • N-acetylcysteine (NAC) supplements, which enhance cysteine production
  • Betaine supplements, which support methylation
  • Certain antiepileptic drugs that affect folate metabolism
  • Hormone replacement therapy containing estrogen

Health Implications of Very Low Homocysteine

While low homocysteine is generally considered less problematic than elevated levels, extremely low concentrations may have health implications. Research suggests that very low homocysteine might be associated with peripheral neuropathy in some individuals, possibly due to disrupted sulfur metabolism. Additionally, homocysteine plays a role in producing glutathione, a crucial antioxidant, so extremely low levels might theoretically impact antioxidant defenses.

Some studies have also suggested potential links between very low homocysteine and certain psychiatric conditions, though more research is needed to establish causation. The key is maintaining balance rather than driving levels as low as possible.

Testing and Monitoring Your Homocysteine Levels

If you suspect you have very low homocysteine levels or are experiencing unexplained symptoms, testing can provide valuable insights. A simple blood test can measure your homocysteine levels, and when combined with other metabolic markers, can help identify underlying causes.

Important markers to test alongside homocysteine include:

  • Vitamin B12 and folate levels
  • Liver function tests (ALT, AST, albumin)
  • Complete blood count
  • Comprehensive metabolic panel
  • Methylmalonic acid (MMA) for B12 status

Regular monitoring is particularly important if you're taking B-vitamin supplements, have liver disease, or follow a restrictive diet. Understanding your homocysteine levels in the context of your overall health can help guide appropriate interventions.

Managing Very Low Homocysteine Levels

Adjusting Supplementation

If excessive B-vitamin supplementation is the cause, the solution is often straightforward: reduce or temporarily discontinue supplements under medical guidance. Work with a healthcare provider to find the optimal dosage that maintains healthy homocysteine levels without driving them too low. This might involve switching from high-dose supplements to lower doses or obtaining nutrients from food sources instead.

Addressing Nutritional Deficiencies

For those with low homocysteine due to malnutrition or protein deficiency, the focus should be on improving overall nutritional status. This includes:

  • Increasing protein intake from quality sources
  • Ensuring adequate caloric intake
  • Working with a registered dietitian for meal planning
  • Addressing any underlying eating disorders or gastrointestinal issues

Supporting Liver Health

If liver dysfunction is contributing to low homocysteine, supporting liver health becomes crucial. This may involve treating underlying liver conditions, avoiding alcohol and hepatotoxic substances, maintaining a healthy weight, and ensuring adequate nutrition to support liver regeneration and function.

Finding the Right Balance

Very low homocysteine levels, while less common and generally less concerning than elevated levels, can still indicate underlying health issues that deserve attention. Whether caused by over-supplementation, nutritional deficiencies, liver problems, or genetic factors, understanding the root cause is essential for appropriate management.

The goal isn't to achieve the lowest possible homocysteine level but rather to maintain levels within the optimal range that supports overall health. This requires a balanced approach to nutrition, appropriate supplementation when needed, and regular monitoring to ensure your metabolic pathways are functioning properly. By understanding what drives very low homocysteine and taking appropriate action, you can optimize your health and prevent potential complications associated with metabolic imbalances.

References

  1. Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6 Suppl):1731S-1740S.[PubMed][DOI]
  2. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999;131(5):331-339.[PubMed][DOI]
  3. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int. 1997;52(2):495-502.[PubMed][DOI]
  4. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193-200.[PubMed][DOI]
  5. Bleie Ø, Semb AG, Grundt H, et al. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med. 2007;262(2):244-253.[PubMed][DOI]
  6. García-Tevijano ER, Berasain C, Rodríguez JA, et al. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension. 2001;38(5):1217-1221.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my homocysteine at home?

You can test your homocysteine at home with SiPhox Health's Heart & Metabolic Program, which includes homocysteine testing along with other cardiovascular and metabolic biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is considered a very low homocysteine level?

Very low homocysteine is typically defined as levels below 5 μmol/L. Normal ranges are generally between 5-15 μmol/L, with optimal levels considered to be 6-10 μmol/L. Levels below 5 may indicate over-supplementation, malnutrition, or other metabolic issues.

Can taking too many B vitamins cause low homocysteine?

Yes, excessive supplementation with B vitamins, particularly folate, B12, and B6, is the most common cause of very low homocysteine. These vitamins enhance the conversion of homocysteine to other compounds, potentially driving levels below normal when taken in high doses.

Should I be concerned about low homocysteine levels?

While low homocysteine is generally less concerning than high levels, extremely low levels (below 5 μmol/L) may indicate underlying issues like malnutrition, liver problems, or over-supplementation. It's worth investigating the cause, especially if you have other symptoms.

How often should I test my homocysteine levels?

If you have very low homocysteine or are adjusting supplementation, testing every 3-6 months is reasonable. Those with liver disease or on high-dose B vitamins may benefit from more frequent monitoring to ensure levels remain in the optimal range.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details